The Immunology of Long COVID

Purpose: This review aims to synthesize contemporary evidence elucidating the immunopathological mechanisms underlying Long COVID, with particular emphasis on chronic immune dysregulation as a central pathophysiological driver. 
Materials and Methods: We conducted a comprehensive narrative review of peer-reviewed literature published between 2020 and 2025, examining human cohort studies, experimental models, and mechanistic investigations. Electronic databases were searched for studies reporting immunological parameters in Long COVID patients, including adaptive and innate immune markers, autoantibody profiles, viral persistence data, and biomarker analyses. 
Results: The analysis reveals multiple interconnected pathophysiological pathways: (1) profound T-cell exhaustion characterized by elevated PD-1 and TIM-3 expression with diminished central memory CD4+ populations; (2) B-cell compartment alterations including reduced switched memory subsets and expanded plasmablast populations; (3) sustained elevations in pro-inflammatory cytokines (IL-6, IL-8, IFN-γ) and chemokines (CXCL9, CXCL10); (4) autoantibody generation targeting neural, vascular, and autonomic receptors; (5) demonstrable viral persistence in gastrointestinal and neural tissues; (6) endothelial dysfunction with fibrin-amyloid microclot formation; (7) neuroinflammatory processes involving glial activation and blood-brain barrier compromise; (8) mitochondrial bioenergetic failure; and (9)complement cascade dysregulation. These mechanisms establish self-perpetuating cycles of immune dysfunction bearing notable resemblance to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Conclusion: Long COVID can be understood as as a multifactorial post-viral syndrome driven by persistent immune dysregulation rather than direct viral cytopathic effects. The convergence of cellular exhaustion, chronic inflammation, autoimmunity, and tissue resident viral reservoirs creates a complex pathological state requiring targeted therapeutic interventions and biomarker-guided precision medicine approaches. (Open J Biomed Res 2025;4:13-17)